THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -98.9% | 3,700 | -59.0% | 0.00% | -100.0% |
| Q4 2021 | $95,000 | +9400.0% | 9,023 | -24.2% | 0.00% | – |
| Q3 2021 | $1,000 | -97.8% | 11,900 | +83.1% | 0.00% | -100.0% |
| Q1 2021 | $45,000 | +36.4% | 6,500 | +62.5% | 0.00% | +100.0% |
| Q1 2020 | $33,000 | +371.4% | 4,000 | +928.3% | 0.00% | 0.0% |
| Q3 2019 | $7,000 | -98.3% | 389 | -99.0% | 0.00% | -97.4% |
| Q2 2019 | $413,000 | +68.6% | 37,646 | +32.1% | 0.04% | +56.0% |
| Q1 2019 | $245,000 | +24400.0% | 28,500 | +470.0% | 0.02% | – |
| Q2 2018 | $1,000 | -75.0% | 5,000 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |